INS and Insulin resistance: We evaluated the effect of APPxhQC transgenes and T2D induction on fasting plasma insulin levels (FPI), fasting plasma glucose levels (FPG), homeostatic model assessment for insulin resistance (HOMA-IR) and homeostasis model assessment of beta-cell function (HOMA-β).